Print page Resize text Change font-size Change font-size Change font-size


Drug Consumption Databases in Europe

The inventory of Drug Consumption Databases in Europe is a comprehensive and structured source of information on drug consumption in Europe. It comprises two documents. The master document contains a detailed report of the available information, methods to retrieve this information, a description of the validity of national drug consumption data and a discussion. The country profile document summarizes the main results by country.

DRUG CONSUMPTION DATABASES IN EUROPE:
MASTER AND COUNTRY PROFILE DOCUMENTS


These documents are the result of reviewing, compiling and updating knowledge about European sources of data on drug utilisation in the out- and inpatient healthcare sector.
Two documents are available to view. A master document, organised as a scientific article, contains a detailed report of the information already available, methods to retrieve this information, and a discussion.

The country profile document summarizes the main results by country.

Summary of the included information:


Master document and country profile document

List of non-commercial providers of drug consumption data in Europe

List of national medicines agencies, reimbursement and pricing agencies

List of sources of information about medicines

List of nationwide drug consumption databases in Europe with a description of the main characteristics and accessibility

Master document Summary of data provided by IMS Health, Inc.
Exploration of the availability of nationwide inpatient drug consumption data
Outline of validity and degree of inter-country comparability of drug consumption data
International networks and research working groups in pharmacoepidemiology



Information is available for Belgium, Federation of Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Montenegro, Norway, Poland, Portugal, Slovakia,  Slovenia, Spain, Sweden, The Netherlands, The United Kingdom and Turkey. Information was last updated in February 2015.


These documents are a shared resource for researchers, regulatory agencies, and pharmaceutical companies.
We encourage all readers to review and comment on these documents.


For queries and comments, please contact Dr Luisa Ibáñez or Dr Joan Fortuny

 

 

>>Inventory on Drug Consumption MASTER DOCUMENT (February 2015)

>> Inventory on Drug Consumption COUNTRIES SUMMARY (February 2015)